Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Mizushima N
Chemical Name: 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3R)-piperidin-3-yl]-1H
Inhibitor of macrophage stimulation and interleukin-1 production
the two higher doses of Cariprazine also lead to a significant decrease in the total number of arm entries (F(5
Neuropsychopharmacology 33 2362
Canagliflozin - CAS# 842133-18-0 Catalog No.:M10730-10 Mizushima NCanagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the
US$ 34.95
US$ 29.95
US$ 43.95
US$ 39.95
US$ 65.95
US$ 19.95
US$ 132.95
US$ 29.95
US$ 109.97
US$ 29.95
US$ 10.95
US$ 20.95